Your browser doesn't support javascript.
loading
MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript.
Cassius, Charles; Amode, Reyhan; Delord, Marc; Battistella, Maxime; Poirot, Justine; How-Kit, Alexandre; Lepelletier, Clémence; Jachiet, Marie; de Masson, Adèle; Frumholtz, Laure; Cordoliani, Florence; Boccara, David; Lehmann-Che, Jacqueline; Wong, Jennifer; Dubanchet, Sylvie; Alberdi, Antonio José; Merandet, Marine; Bagot, Martine; Bensussan, Armand; Bouaziz, Jean-David; Le Buanec, Hélène.
Afiliação
  • Cassius C; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; Université Catholique de Louvain, CHU UCL Namur, Belgium; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Der
  • Amode R; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology,
  • Delord M; Direction à la recherche clinique et à l'innovation, Centre hospitalier de Versailles, Le Chesnay, France.
  • Battistella M; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Pathology Department, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Poirot J; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France.
  • How-Kit A; Laboratory for Genomics, Foundation Jean Dausset-CEPH, Paris, France.
  • Lepelletier C; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology,
  • Jachiet M; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology, French Society of Dermatology), Paris, France.
  • de Masson A; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Frumholtz L; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology, French Society of Dermatology), Paris, France.
  • Cordoliani F; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Boccara D; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Plastic, Reconstructive, and Cosmetic and Burn Surgery Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Lehmann-Che J; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Wong J; Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Dubanchet S; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France.
  • Alberdi AJ; Université de Paris, Technological Core Facility, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France.
  • Merandet M; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France.
  • Bagot M; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Bensussan A; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France.
  • Bouaziz JD; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France; Dermatology Department, AP-HP, Hôpital Saint-Louis, Paris, France; EMSED (Etude des Maladies Systémiques en Dermatologie, Société Française de Dermatologie/Study Group of Systemic Diseases in Dermatology,
  • Le Buanec H; Université de Paris, Inserm U976 - HIPI Unit, Institut de Recherche Saint-Louis, Paris, France.
J Invest Dermatol ; 140(6): 1276-1279.e7, 2020 06.
Article em En | MEDLINE | ID: mdl-31955963
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Regulação da Expressão Gênica / Dermatomiosite / Helicase IFIH1 Induzida por Interferon Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Regulação da Expressão Gênica / Dermatomiosite / Helicase IFIH1 Induzida por Interferon Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Ano de publicação: 2020 Tipo de documento: Article